Breaking News

ICON to Acquire MediMedia Pharma Solutions

Expands market access services and scientific communications capabilities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ICON plc has agreed to acquire MediMedia Pharma Solutions for $120 million in cash, adding expertise in scientific communications and market access to ICON’s Commercialization and Outcomes services. Owned by Vestar Capital Partners, MediMedia supports development launches and in-market products spanning numerous therapeutic classes. Ciaran Murray, ICON chief executive officer, said, “The need to demonstrate and communicate the value of new medicines is an important global healthcare trend. Thro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters